Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) in Biopharmaceutical Market 

5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Biopharmaceutical Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence (AI) in Biopharmaceutical Market, By Application

8.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Application, 2023-2032

8.1.1. Drug Discovery

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Precision Medicine

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Medical Imaging & Diagnostics

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Research

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Artificial Intelligence (AI) in Biopharmaceutical Market, By Technology

9.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Technology, 2023-2032

9.1.1. Machine Learning

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Natural Language Processing

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Deep Learning

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Artificial Intelligence (AI) in Biopharmaceutical Market, By Offering 

10.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Offering, 2023-2032

10.1.1. Hardware

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Software

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Services

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Artificial Intelligence (AI) in Biopharmaceutical Market, By Deployment 

11.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Deployment, 2023-2032

11.1.1. Cloud

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. On-Premises

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Artificial Intelligence (AI) in Biopharmaceutical Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.3. Market Revenue and Forecast, by Offering (2020-2032)

12.1.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Offering (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.3. Market Revenue and Forecast, by Offering (2020-2032)

12.2.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Offering (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Offering (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Offering (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.3. Market Revenue and Forecast, by Offering (2020-2032)

12.3.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Offering (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Offering (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Offering (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.3. Market Revenue and Forecast, by Offering (2020-2032)

12.4.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Offering (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Offering (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Offering (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Offering (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Deployment (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Offering (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Deployment (2020-2032)

Chapter 13. Company Profiles

13.1. IBM Watson Health

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Google Health

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. NVIDIA Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Microsoft Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. DeepMind

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Atomwise

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Insilico Medicine

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. PathAI

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Tempus

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. GNS Healthcare

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms